In line with its important roles in cancer cell migration, invasion, and DNA damage response, ERK3 is upregulated in multiple cancers, including non‐small‐cell lung cancer (Long et al., 2012), gastric cancer (Liang et al., 2005), and oral squamous cell carcinoma (Rai et al., 2004). The gene discussed is MAPK6; the disease is cancer.